BioSpace News Archive

Eagle Pharmaceuticals, Inc. announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two upcoming conferences in September.

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, announced that management will participate in two upcoming virtual investor conferences in September

BrainsWay Ltd., a global leader in the advanced non-invasive treatment of brain disorders, announced that Christopher von Jako, Ph.D., President and Chief Executive Officer, will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Tuesday, September 22 at 1:40 PM ET.

Designation Based on PROTECTIVE-2 Phase 3 Interim Data, Reinforcing Significant Treatment Need in CIN

Axsome Therapeutics, Inc., a biopharmaceutical company developing novel therapies for the management of central nervous system disorders, announced that Herriot Tabuteau, MD, Axsome’s Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17, 2020 at 10:15 AM Eastern Time.

Athenex’s oral paclitaxel plus encequidar is being evaluated in combination with GSK’s dostarlimab in the neoadjuvant chemotherapy setting

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced that management will host an investor conference call to discuss AUTO3 data presented at the European Society for Medical Oncology Virtual Congress 2020 and to participate in Banking conferences through September

Intec Pharma Ltd. announces that the Company management will present at the virtual H.C. Wainwright 22nd Annual Global Investment Conference.

Alkermes plc announced that it will present new clinical data related to ALKS 4230, its investigational engineered interleukin-2 variant immunotherapy, at the European Society for Medical Oncology Virtual Congress, taking place Sept. 18-21, 2020.

Concert Pharmaceuticals, Inc. announced that it will participate at the following upcoming virtual investor conferences:.